title: Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.
abstract: OBJECTIVE
  This study evaluated the causes of syncope and the significance and differences in left ventricular (LV) dysfunction, coronary disease, and idiopathic dilated cardiomyopathy (DCM).
  
  
  BACKGROUND
  Risk stratification of and indications for an automated defibrillator could differ according to the cause of LV dysfunction.
  
  
  METHODS
  Electrophysiologic study, including atrial and ventricular programmed stimulation, was performed in 119 patients with coronary disease (group I) and 61 patients with DCM (group II) with an left ventricular ejection fraction (LVEF) <40% and syncope. Patients were followed from one to six years (mean 4 +/- 2 years).
  
  
  RESULTS
  Sustained monomorphic ventricular tachycardia (VT) was induced in 44 group I patients (37%) and 13 group II patients (21%); ventricular flutter (>270 beats/min) or ventricular fibrillation (VF) was induced in 24 group I patients (19%) and 9 group II patients (15%); and various other arrhythmias were identified. Syncope remained unexplained in 34 group I patients (30%) and 16 group II patients (27%). Prognosis depended on the heart disease: VT or VF induction was a predictive factor of mortality in coronary disease and identified a group with high cardiac mortality (46%), compared with patients with a negative study, who had a lower mortality (6%; p < 0.001) than in other studies. Cardiac mortality was only correlated with LVEF in DCM.
  
  
  CONCLUSIONS
  Various causes could explain syncope in 70% of patients with coronary disease and DCM, but differences were noted: VT was frequent in coronary disease with a bad prognosis, and ischemia could explain syncope; in DCM, different causes such as atrial tachycardia could be responsible for syncope, but the prognosis only depended on LVEF.
authors.affiliation: Department of Cardiology, CHU of Brabois, Vandoeuvre Les Nancy, France. b.brembilla-perrot@chu-nancy.fr
authors.forename: Béatrice
authors.initials: B
authors.lastname: Brembilla-Perrot
authors.forename: Christine
authors.initials: C
authors.lastname: Suty-Selton
authors.forename: Daniel
authors.initials: D
authors.lastname: Beurrier
authors.forename: Pierre
authors.initials: P
authors.lastname: Houriez
authors.forename: Marc
authors.initials: M
authors.lastname: Nippert
authors.forename: Arnaud Terrier
authors.initials: AT
authors.lastname: de la Chaise
authors.forename: Pierre
authors.initials: P
authors.lastname: Louis
authors.forename: Olivier
authors.initials: O
authors.lastname: Claudon
authors.forename: Marius
authors.initials: M
authors.lastname: Andronache
authors.forename: Ahmed
authors.initials: A
authors.lastname: Abdelaal
authors.forename: Ahmed
authors.initials: A
authors.lastname: Abdelaah
authors.forename: Nicolas
authors.initials: N
authors.lastname: Sadoul
authors.forename: Yves
authors.initials: Y
authors.lastname: Juillière
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002311:Cardiomyopathy, Dilated / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D003324:Coronary Artery Disease / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D017147:Defibrillators, Implantable; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D013318:Stroke Volume; D016019:Survival Analysis; D013575:Syncope / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control*; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000150:complications* / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000150:complications / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*